Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung CancerEmma Pailler, Vincent Faugeroux, Marianne Oulhen, et al.NPJ Precision Oncology|May 13, 2026
The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinibMai Nagasaka, Francesco Facchinetti, Ludovic Bigot, et al.Cell Cycle (Georgetown, Tex.)|September 17, 2013
ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoformLuc Friboulet, Sophie Postel-Vinay, Tony Sourisseau, et al.JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outsKen A Olaussen, Julien Adam, Elsa Vanhecke, et al.Clinical Lung Cancer|June 19, 2013
19q13-ERCC1 gene copy number increase in non--small-cell lung cancerElsa Vanhecke, Alexander Valent, Ximing Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and CeritinibJustin F Gainor, Daniel S W Tan, Tomasso De Pas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN AlterationsUrsula Grazini, Aleksandra Markovets, Lucy Ireland, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2026
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLCSandra Ortiz-Cuaran, Laurine Dupriez, Constance Nicq, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.Pageof 7